{"id":"W2022706281","doi":"10.1158/1535-7163.targ-11-a143","title":"Abstract A143: ARRY-380, a selective HER2 inhibitor: From drug design to clinical evaluation.","year":2011,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Kingston General Hospital","funders":"","keywords":"Pharmacokinetics; Pharmacology; Kinase; Drug; Potency; Metastatic breast cancer; Tyrosine-kinase inhibitor; Medicine; Cancer; Chemistry; Breast cancer; Cancer research; Internal medicine; In vitro; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001745425,0.0003425168,0.0005359605,0.0001625263,0.00009963118,0.00004593922,0.0003641239,0.000257248,0.001645906],"category_scores_gemma":[0.000161191,0.0003193172,0.0002415114,0.0005406017,0.0001608904,0.00007285552,0.00009124363,0.0008342298,0.000338876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007652486,"about_ca_system_score_gemma":0.00206567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00167242,"about_ca_topic_score_gemma":0.0002368479,"domain_scores_codex":[0.9959335,0.0005552204,0.0006625554,0.0007945616,0.001410254,0.0006438591],"domain_scores_gemma":[0.997477,0.0002070974,0.0001465981,0.0008666458,0.0008270036,0.0004756417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005455342,0.002025618,0.04434065,0.0001249414,0.003891628,0.0005576905,0.01499807,0.0004205173,0.1602484,0.00008306697,0.02228275,0.7455713],"study_design_scores_gemma":[0.007762658,0.001819188,0.116485,0.0007230052,0.001574988,0.00001754244,0.0006224409,0.003233847,0.8027264,0.004270824,0.05953601,0.00122804],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9269699,0.01376309,0.03446997,0.005465688,0.002320869,0.006510867,0.0001268966,0.000362203,0.01001051],"genre_scores_gemma":[0.9804429,0.0005031112,0.009402084,0.007985017,0.0006816472,0.0005936514,0.00001866594,0.0001430809,0.0002298534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7443433,"threshold_uncertainty_score":0.9999259,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2361001896785956,"score_gpt":0.4558990134427958,"score_spread":0.2197988237642002,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}